Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 14/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL885209 | 0.93 | PDE4D (0.49) | PDE4DCNR2PDE4APDE4BPDE4C | |
| SCHEMBL884919 | 0.92 | PDE4D (0.48) | PDE4DCNR2PDE4APDE4BPDE4C | |
| SCHEMBL886793 | 0.91 | PDE4D (0.48) | PDE4DCNR2PDE4APDE4BPDE4C | |
| SCHEMBL885375 | 0.91 | PDE4D (0.41) | PDE4DCNR1CNR2PDE4APDE4B | |
| SCHEMBL885330 | 0.90 | PDE4D (0.46) | PDE4DNPBWR1MCHR1 | |
| SCHEMBL885267 | 0.90 | PDE4D (0.42) | PDE4DCNR1CNR2 | |
| SCHEMBL885291 | 0.89 | PDE4D (0.46) | PDE4DPDE4APDE4BPDE4C | |
| SCHEMBL885212 | 0.88 | PDE4D (0.45) | PDE4DPDE4APDE4BPDE4CNPBWR1 | |
| SCHEMBL885364 | 0.88 | PDE4D (0.40) | PDE4DCNR1CNR2NPBWR1MCHR1 | |
| SCHEMBL886775 | 0.87 | PDE4D (0.48) | PDE4DPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2925364-A1 | A METHOD OF INHIBITING THE EXPRESSION OF IL-22 IN ACTIVATED T-CELLS | Leo Pharma A/S (DK) | 2015-10-07 | — | — | EP | disclosed |
| WO-2014083099-A1 | A METHOD OF INHIBITING THE EXPRESSION OF IL-22 IN ACTIVATED T-CELLS | LEO PHARMA A/S (DK) | 2014-06-05 | — | — | WO | disclosed |
| EP-2125736-A1 | SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS | Leo Pharma A/S (DK) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008077404-A1 | SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS | LEO PHARMA A/S (DK) | 2008-07-03 | — | — | WO | disclosed |